I found this, concerning that, from toolongforshor

I found this, concerning that, from toolongforshorts on YMB,

"Here's the thing with Regnum: We signed an agreement with Vyera (Skireli Pharma Bro Co.) for commercialization and distribution of LL in the US. Vyera is toast, they've been sued by the states' AGs and they are going under. Regnum was a shell owned by Vyera, now being sold to Sevenscore (represented in documents by the CEO of Phoenixus) along with the US commercialization rights for LL for a couple $mil. It plays out that Sevenscore is the new company commercializing our drug and seemingly comprised of the C-suite of Phoenixus AG. The transfers of these rights and shell company is happening for a tiny sum and in a tax-free manner. Basically, the C-suite of our partner is shedding the pharma bro company and taking all the assets with them. The optics aren't great, but the team that is taking the rights has proven experience. Right now, it is no better or worse for us than being partnered with Vyera. Other than possibly distancing ourselves from that dumpster fire."